ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Approves Gilteritinib
americanpharmaceuticalreview
November 30, 2018On November 28, 2018, the Food and Drug Administration (FDA) approved gilteritinib (XOSPATA, Astellas Pharma) for treatment of adult patients who have relapsed or refractory....... -
FDA grants priority review to Astellas’ NDA for gilteritinib
pharmaceutical-technology
June 01, 2018The US Food and Drug Administration (FDA) has accepted Astellas Pharma’s new drug application (NDA) for gilteritinib and granted priority review for the product’s use in the treatment of acute myeloid leukaemia (AML).
Pharma Sources Insight January 2025
